FDA Approved: GALLIUM GA-68 PSMA-11 — Original Application (UCSF Radiopharmaceutical Facility)

View source ↗

Summary

FDA approved Gallium-68 PSMA-11 (gallium-68 gozetotide) for PET imaging to detect PSMA-expressing lesions in adult men with suspected prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GALLIUM GA-68 PSMA-11 (Gallium-68 gozetotide)

Snippet

ORIG AP for GALLIUM GA-68 PSMA-11 (GALLIUM GA-68 GOZETOTIDE)